Treatment of GH3 cells with thyrotropin-releasing hormone (TRH) for periods up to 60min resulted in a prolonged reduction in the cellular content of phosphatidylinositol (PtdIns) with no lasting change in the levels of the other inositol-containing phospholipids. Accompanying this was a maintained increase in the GH3 cell 1,2-diacylglycerol content and a slower decline in the level of cellular triacylglycerol. When the cells were suspended in lithium-containing balanced salt solution for 30min (in the absence of exogenous myo-inositol), there was a 15% decrease in GH3 cell inositol levels. This was associated with a small, but significant, increase in the cellular content of phosphatidylinositol 4,5-bisphosphate (Ptdlns4,5P2) and 1,2-diacylglycerol. Addition of TRH to cells suspended in lithium-containing medium depleted cellular inositol levels by around 65% within 30min. By this time, there was also a 50% reduction in the cellular content of Ptdlns and a 20% reduction in phosphatidylinositol 4-phosphate (PtdIns4P). Control levels of PtdIns4,5P2 were maintained in the combined presence of TRH and lithium. Under those conditions, TRH no longer depleted cellular triacylglycerol and there was a marked increase in the ability of TRH to elevate the GH3 cell content of 1,2-diacylglycerol. The-effect of TRH on the cellular content of phosphatidic acid was not altered by the presence of lithium. The results show, firstly, that when PtdIns resynthesis is inhibited by lithium-induced inositol depletion, its glycerol backbone accumulates, at least in part, in 1,2-diacylglycerol and, secondly, that GH3 cells preserve their cellular levels of PtdIns4,5P2 in the face of a considerable reduction in the cellular content of Ptdlns.
For the past three decades, it has been well documented that receptor agonists that mobilize calcium also increase the metabolism of PtdIns (Downes & Michell, 1982) . Indeed, Michell has proposed that changes in the metabolism of PtdIns are necessary for calcium mobilization to occur (Michell, 1975) . In the past year it has become apparent that the initial step in the alteration of inositol lipid metabolism is the agonist-induced hydrolysis of the polyphosphoinositides, PtdIns4P
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and, in particular, Ptdlns4,5P2, by a phospholipase C-type enzyme (for a recent review, see Berridge, 1984) . Breakdown of Ptdlns4,5P2 in this fashion yields 1,2-diacylglycerol, which can activate protein kinase C (Takai et al., 1979) , and InsP3, which has recently been shown to mobilize calcium from intracellular stores (Streb et al., 1983) . One of the limitations of research in this area of cell biology has been the absence, until recently, of pharmacological agents which perturb the inositol lipid cycle in a specific or even selective manner. Berridge and his collaborators (Berridge et al., 1982) have recently followed up the original investigations of Allison (Allison & Stewart, 1971; Allison &-Blisner, 1976) who showed that lithium ions selec-phosphate. Under conditions in which the cell has no source of exogenous myo-inositol, the presence oflithium can lead to a relatively rapid reduction of intracellular levels and, subsequently, to a depletion of cellular inositol-containing phospholipids.
GH3 cells are a clonal line of rat pituitary tumour cells which respond to a number of receptor agonists by releasing prolactin in a calciumdependent manner (for a review, see Martin & Tashjian, 1977) . A number of laboratories, including our own, have recently shown that one of these agents, TRH, also stimulates inositol lipid metabolism in GH3 cells (Drummond & Macphee, 1981; Rebecchi et al., 1981; Schlegel et al., 1981; Sutton & Martin, 1982) . TRH increases the GH3 cell content of PtdA and 1,2-diacylglycerol and, at the same time, reduces cellular levels of PtdIns by 10-15% (Drummond & Macphee, 1981; . Recent work has shown that, in this cell type also, the initial reaction of the cell to the presence of the agonist (TRH) is the hydrolysis of Ptdlns4,5P2 and, perhaps, of PtdIns4P Martin, 1983; Schlegel et al., 1984) . GH3 cells, then, are a convenient model system with which to investigate stimulated inositol lipid metabolism. Previous work from this laboratory has demonstrated that lithium treatment of GH3 cells can deplete cellular inositol-containing phospholipids . However, it remains unclear, in any cell type, whether all three inositol phospholipids are depleted equally under these conditions. The fate of the glycerol backbone of the depleted lipids is also unknown. These are the subjects of the present investigation, which shows, firstly, that GH3 cells retain their normal levels of PtdIns4,5P2 despite a large decrease in the cellular Ptdlns content and, secondly, that the glycerol backbone of the depleted Ptdlns accumulates, at least in part, in 1,2-diacylglycerol. (Rebecchi et al., 1981 ) and prepared as previously described of Calderon et al. (1979) . All other phospholipids were separated by two-dimensional t.l.c. on silica gel G plates as described by Yavin & Zutra (1977) . In all cases, lipids were identified by comparison with reference standards detected with I2 vapour. Spots/ bands were scraped and incorporated radioactivity was quantified by liquid-scintillation spectrometry.
Experimental

Measurement of cellular inositol and its acid-soluble metabolites
Cell suspensions (0.5ml), prelabelled with [3H]inositol as indicated in the Table legend, were incubated with or without TRH, in the presence or absence of lithium, for 30min at 37°C. At the end of the incubation period, 1.5 ml of ice-cold BSS was added to the cells and samples were centrifuged at 650g for 5 min at 4°C. The supernatant, which contains any extracellular inositol, was discarded and the inositol-containing substances present in the cell pellet were released by the addition of 1 ml of 10% (w/v) trichloroacetic acid. These inositol metabolites were measured as previously described .
Protein determination
The protein content of the suspended cells was determined by the method of Lowry et al. (1951) using bovine serum albumin (Miles) as standard. In each experiment, separate aliquots were taken for this purpose. The cells in these aliquots were washed twice by centrifugation (200g, 3min) and resuspension in 0.9% (w/v) iso-osmotic saline to remove the 0.1% bovine serum albumin present in BSS. The cell pellet was finally dissolved in 0.1 MNaOH before assay.
Results
Effect oflithium and TRH on the GH3 cell content of acid-soluble inositol metabolites
The addition of TRH to suspensions of GH3 cells led to a lasting accumulation of all four inositol-containing metabolites , and see Table 1 ). The presence of 10mM-lithium in the BSS caused, by itself, a 2.8-fold increase in the cellular Ins 1 P content within 30 min and also resulted in a small reduction in inositol levels (Table 1) . When both TRH and lithium were present there was a very marked potentiation both of InsIP formation (up to 50-fold above control) and of InsP2 formation (9-fold above control). InsP3 levels were relatively insensitive to the presence of lithium. Under these conditions, greater than 65% of the cellular inositol had been depleted ( (Table 2 ). This occurs without any significant change in the incorporation of isotope into PtdA (Table 2 ). Note also that the TRH-stimulated incorporation of [32p]p; into phosphatidylcholine is markedly decreased by the inclusion of lithium. Cell suspensions (0.5 ml), pre-labelled for 3 days with [3H]inositol (5 sCi/dish), were incubated in the presence of the appropriate substances for 30min at 37°C. The reaction was terminated by the addition of 3 vol. of ice-cold BSS and the metabolites measured as described in the Experimental section. Because of the variation in the absolute levels of the metabolites from experiment to experiment, the results are expressed as percentages of the mean control sample. was a 10-20% reduction in the GH3 cell PtdIns content (Table 3) . When TRH was added to GH3 cells suspended in lithium-containing medium there was a marked depletion in the Ptdlns content (Table 3; Fig. 1 . Effect of lithium and TRH, alone and in combination, on the GH3 cell content of 1,2-diacylglycerol and triacylglycerol Cell suspensions (0.5 ml), prelabelled for 4 days with [3H]glycerol (1 00 Ci/dish), were incubated with the appropriate substances for times up to 60min. The reactions were stopped and the neutral lipids extracted and separated as described in the Experimental section. 
Effect oflithium and TRHon other GH3 cellphospholipids
The data presented in Table 4 show that TRH, unlike lithium, also increased the GH3 cell content of PtdA and CDP-diacylglycerol. Although the effect of TRH on CDP-diacylglycerol levels appeared to be slightly magnified in the presence of lithium, the TRH-induced PtdA accumulation was entirely unaffected ( Fig. 1 indicate that this is, most likely, the case. Addition of TRH to GH3 cells elicited a rise in their 1,2-diacylglycerol content which persisted for 40min. In addition, the peptide also induced a fall in the level of triacylglycerol which, while developing more slowly than the effects on 1,2-diacylglycerol, was statistically significant within 40min and increased over the remainder of the incubation period (Fig. 1) . When TRH was added to lithium-containing BSS, there was a marked increase in the ability of TRH to elevate cellular 1,2-diacylglycerol levels, a response that was maintained for at least 1 h (Fig. 1) . Interestingly, TRH did not deplete cellular triacylglycerol when it was added to GH3 cells in the presence of lithium (Fig. 1) . Incubation of GH3 cells in lithium-containing BSS for 60min resulted, by itself, in a small elevation of 1,2-diacylglycerol levels that was statistically significant within 40min (Fig. 1) .
Discussion
A number of recent studies have emphasized the multi-functional nature of the inositol phospholipid signalling system (Berridge, 1981; Nishizuka, 1984 Ptdlns4,5P2 by phospholipase C, InsP3, may be involved in short-term changes due to its ability to mobilize cellular calcium (Streb et al., 1983) , while the other, 1,2-diacylglycerol, may, by activating protein kinase C, lead to longer-lasting changes in cellular function (Zawilich et al., 1983) . It remains unclear whether both of these mechanisms are employed in GH3 cells, although it has been suggested that the long-term stimulatory effects of TRH on prolactin biosynthesis are related to activation of protein kinase C, while TRH-induced prolactin release may be a response to an increase in cytoplasmic free calcium concentrations (Sobel & Tashjian, 1983) . Addition of TRH to suspensions of GH3 cells leads to a transient increase in the cytoplasmic free calcium concentration (Gershengorn & Thaw, 1983) and to an increase in cellular 1,2-diacylglycerol levels which reaches a steady-state value after 5 min of exposure to the peptide Martin, 1983; . The results presented in the present paper show that the increase in 1,2-diacylglycerol levels, observed after TRH, persists for at least 40-60min. This is reminiscent of previous work demonstrating long-term changes in PtdA and Ptdlns levels after the addition of TRH to GH3 cells , and is consistent with the possibility that the continued activation of protein kinase C by 1,2-diacylglycerol may underlie changes in prolactin synthesis. Previous studies have indicated that the TRH-induced decrease in cellular polyphosphoinositides is a transient phenomenon which has partially (Rebecchi Martin, 1983) or completely reversed within 5min. These results agree with the present data which indicate that the levels of Ptdlns4,5P2 are back within the control range 30min after the addition of TRH.
A primary aim of the present investigation was to determine the fate of the glycerol backbone of the inositol-containing phospholipids as their resynthesis is inhibited by lithium treatment. The reduction in the cellular concentration of inositol induced by lithium or a combination of lithium and TRH might be expected to compromise resynthesis of PtdIns, since the Km of the enzyme CDPdiacylglycerol: myo-inositol transferase for inositol, in liver at least, is 2.5 mM (Takenawa & Egawa, 1977) and the GH3 cell concentration is calculated to be about 0.3mM . It thus seems likely that the content of inositol will be a limiting factor in GH3 cell Ptdlns biosynthesis. (Pollard & Brindley, 1984) . The present data are entirely consistent with this finding, but further work is obviously necessary to test if TRH can activate the enzyme in GH3 cells and whether such an effect fully explains the time-course of TRH-induced PtdA production.
Treatment of GH3 cells with lithium in the absence of an agonist also led to a small increase in their content of 1,2-diacylglycerol. This increase was reliably seen in a number of separate experiments. The source of this 1,2-diacylglycerol remains uncertain, since there was no accompanying change in the cellular levels of any other lipid. It should be noted, however, that the amount of 1,2-diacylglycerol formed was relatively small and, had it been produced from Ptdlns, for example, the resultant decline in the Ptdlns content would have been around 3-5%. Such a change would have been very difficult to detect. The most likely source of the 1,2-diacylglycerol is probably Ptdlns (presumably via polyphosphoinositide hydrolysis), since lithium does lead to a small decline in the cellular content of inositol under those conditions. Whatever the mechanism, the findings are of some interest since there is no accompanying change in the cellular content of InsP3 when cells are treated with lithium. If, as Berridge and his collaborators suggest (Streb et al., 1983) , this inositol metabolite is involved in the mobilization of cellular calcium, treatment of cells and tissues with lithium may, under certain conditions, lead to selective activation of protein kinase C in the absence of a change in cytoplasmic free calcium levels. This pharmacological manipulation may, thus, produce similar effects to the addition of phorbol esters which, as Castagna et al. (1982) have recently shown, directly activate protein kinase C. The enhanced accumulation of 1,2-diacylglycerol observed with TRH under inositol-depleting conditions might have a similar significance, in terms of protein kinase C activation, for certain pharmacological and pathological circumstances such as the treatment of mania with lithium and in diabetic neuropathy, both of which are thought to be associated with a decreased cellular inositol content (Allison & Stewart, 1971; Gillon & Hawthorne, 1983) .
The second primary reason for conducting these studies was to investigate whether all three inositol-containing phospholipids are equally sensitive to depletion by lithium. This does not appear to be the case, since GH3 cells maintain normal levels of Ptdlns4,5P2 in the face of a considerable loss of the precursor PtdIns: an indicator, perhaps, of the importance to the cell of preserving high Ptdlns4,5P2 levels. The cellular content of PtdIns4P is decreased by 20% under the same conditions. A number of laboratories have suggested that the agonist, in this case TRH, must stimulate both PtdIns4,5P2 hydrolysis and resynthesis during activation of the inositol lipid cycle (Downes & Wusteman, 1983; Litosch et al., 1983; Drummond et al., 1984) . It is difficult, in the absence of such a dual activation, to explain how Ptdlns4,5P2 levels return relatively rapidly to the control range when the cycle is clearly still in an activated state. The data presented here reinforce this notion, since polyphosphoinositide levels remain high even when the cellular content of their immediate precursor is markedly decreased by treatment of the cells with TRH in the presence of lithium. The mechanisms involved in stimulating Ptdlns4,5P2 resynthesis remain unknown, although it should be noted that there is some evidence that the enzymes of polyphosphoinositide synthesis, in particular PtdIns4P kinase, are subject to control by phosphorylation (Jolles et al., 1980 (Jolles et al., , 1981 Enyedi et al., 1983; Akhtar et al., 1983) . Gispen and his colleagues (Aloyo et al., 1982) have shown that a kinase which is similar to, if not identical with, protein kinase C controls PtdIns4P kinase in rat brain. Further work is obviously necessary to resolve the mechanism underlying agonist-stimulated PtdIns4,5P2 resynthesis.
